Phase 3 Study to Evaluate the Acid-Inhibitory Effect of Multiple Oral Doses of Vonoprazan (TAK-438)
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the acid-inhibitory effect of multiple oral doses
of Vonoprazan (TAK-438) and the relative effect of vonoprazan versus two controls
(esomeprazole and rabeprazole sodium) in healthy Japanese adult male participants with the
CYP2C19 extensive metabolizer (EM) genotype.